Admera Health Reaches Yet Another Significant Milestone, by Achieving New CLEP Approval for PGxOne™ Plus, a 50 Gene Pharmacogenomics Test
16. März 2017 10:31 ET
|
Admera Health, LLC
SOUTH PLAINFIELD, N.J., March 16, 2017 (GLOBE NEWSWIRE) -- Advanced Molecular Diagnostics company, Admera Health, (www.admerahealth.com) announced today that its PGxOne™ Plus has received New...